PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.30%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-4.22%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
15.97%
Positive EBIT growth while ON is negative. John Neff might see a substantial edge in operational management.
15.09%
Positive operating income growth while ON is negative. John Neff might view this as a competitive edge in operations.
-6.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2.56%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.63%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.73%
Share count expansion well above ON's 0.64%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
17.08%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
4.95%
Dividend growth of 4.95% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
34.22%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-197.20%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
29.76%
10Y CAGR of 29.76% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-26.65%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.01%
3Y CAGR of 12.01% while ON is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
-2.10%
Negative 10Y OCF/share CAGR while ON stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
7.60%
OCF/share CAGR of 7.60% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
24.27%
3Y OCF/share CAGR of 24.27% while ON is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
953.20%
10Y net income/share CAGR of 953.20% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
90.10%
Net income/share CAGR of 90.10% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
299.75%
3Y net income/share CAGR of 299.75% while ON is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
302.95%
Equity/share CAGR of 302.95% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
168.64%
Equity/share CAGR of 168.64% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
91.42%
Equity/share CAGR of 91.42% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
21.42%
Dividend/share CAGR of 21.42% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-2.02%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-2.13%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
9.89%
Inventory growth well above ON's 9.46%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.38%
Negative asset growth while ON invests at 3.47%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.45%
Under 50% of ON's 4.71%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.74%
We’re deleveraging while ON stands at 2.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-17.26%
Our R&D shrinks while ON invests at 1.48%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.48%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.